Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2025
National Delphi consensus on laser and energy-based treatments for rosacea.
СтатьяConsensus StatementСистематический обзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Nguyen Lynhda, Seeber Nikolaus, Paasch Uwe, Schaller Martin, Borelli Claudia, Karsai Syrus, Kautz Gerd, Fischer Tanja C, Drosner Michael, Hammes Stefan, Feise Konstantin, Raulin Christian, Kerscher Martina, Gauglitz Gerd, Baron Jens M, Schneider Stefan W, Herberger Katharina
Аннотация
BACKGROUND: Various treatments are available for rosacea, including lasers and energy-based devices (EBDs). However, the specific role of lasers and EBDs in rosacea management remains insufficiently defined in Germany. The aim of the study was to develop a comprehensive expert consensus on the use of lasers and EBDs in the treatment of rosacea.
PATIENTS AND METHODS: A three-phase study was conducted. First, a steering group performed a systematic literature review and meta-analysis. Second, a prospective, multicenter online survey gathered patient-reported experiences and treatment perspectives. Third, a structured, three-round Delphi process was implemented to discuss consensus statements based on the literature and patient input.
RESULTS: A total of 185 patients participated in the survey. Based on the systematic review and patient questionnaire consensus was performed on (1) the role of lasers and EBDs across different rosacea phenotypes, (2) the integration of laser/EBD treatments with combination therapies, and (3) best practices for pre- and post-treatment care. 16 dermatologists contributed to the Delphi process.
CONCLUSIONS: This expert consensus offers practical guidance for incorporating laser and EBD therapies into rosacea treatment strategies. The Delphi process clarifies key aspects of their role in management, their integration into combination therapies and directions for future research.
PATIENTS AND METHODS: A three-phase study was conducted. First, a steering group performed a systematic literature review and meta-analysis. Second, a prospective, multicenter online survey gathered patient-reported experiences and treatment perspectives. Third, a structured, three-round Delphi process was implemented to discuss consensus statements based on the literature and patient input.
RESULTS: A total of 185 patients participated in the survey. Based on the systematic review and patient questionnaire consensus was performed on (1) the role of lasers and EBDs across different rosacea phenotypes, (2) the integration of laser/EBD treatments with combination therapies, and (3) best practices for pre- and post-treatment care. 16 dermatologists contributed to the Delphi process.
CONCLUSIONS: This expert consensus offers practical guidance for incorporating laser and EBD therapies into rosacea treatment strategies. The Delphi process clarifies key aspects of their role in management, their integration into combination therapies and directions for future research.